Richmond, VA (31st August 2010) – Reckitt Benckiser Pharmaceuticals Inc. today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) to manufacture and market Suboxone… (Source: Drugs.com – New Drug Approvals)
Monthly Archives: August 2010
Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (buprenorphine and naloxone) Sublingual Film C-III
Richmond, VA (31st August 2010) – Reckitt Benckiser Pharmaceuticals Inc. today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) to manufacture and market Suboxone… (Source: Drugs.com – New Drug Approvals)
Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Approval for Suboxone (buprenorphine and naloxone) Sublingual Film C-III
Richmond, VA (31st August 2010) – Reckitt Benckiser Pharmaceuticals Inc. today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) to manufacture and market Suboxone… (Source: Drugs.com – New Drug Approvals)
Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
Conclusions: In Malaysia, BUP and BNX IDU occur among heroin IDUs. The introduction of BNX and withdrawal of BUP may have helped to reduce, but did not eliminate the problems with diversion and abuse. (Source: Drug and Alcohol Dependence)
MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
Conclusions: In Malaysia, BUP and BNX IDU occur among heroin IDUs. The introduction of BNX and withdrawal of BUP may have helped to reduce, but did not eliminate the problems with diversion and abuse. (Source: Drug and Alcohol Dependence)
Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
Conclusions: In Malaysia, BUP and BNX IDU occur among heroin IDUs. The introduction of BNX and withdrawal of BUP may have helped to reduce, but did not eliminate the problems with diversion and abuse. (Source: Drug and Alcohol Dependence)
Drug Treatment as HIV Prevention: Expanding Treatment Options
Abstract Research conducted during the first 20 years of the AIDS epidemic provided a solid foundation of data supporting methadone
treatment as HIV prevention. Drug users in methadone treatment were consistently found to reduce the frequency of drug use,
risk behaviors, and infections. These data have been consistent over time and across cultural settings and have been used
to promote the expansion of drug treatment as a prevention intervention. More recently, data have emerged suggesting the prevention
potential of medication-assisted treatments other than methadone (buprenorphine/naloxone and naltrexone). Still, with a few
notable exceptions, global drug treatment coverage for opiate injectors remains remarkably low and only a few treatment interventions
for stimul…
Drug Treatment as HIV Prevention: Expanding Treatment Options
Abstract Research conducted during the first 20 years of the AIDS epidemic provided a solid foundation of data supporting methadone
treatment as HIV prevention. Drug users in methadone treatment were consistently found to reduce the frequency of drug use,
risk behaviors, and infections. These data have been consistent over time and across cultural settings and have been used
to promote the expansion of drug treatment as a prevention intervention. More recently, data have emerged suggesting the prevention
potential of medication-assisted treatments other than methadone (buprenorphine/naloxone and naltrexone). Still, with a few
notable exceptions, global drug treatment coverage for opiate injectors remains remarkably low and only a few treatment interventions
for stimul…
Drug Treatment as HIV Prevention: Expanding Treatment Options
Abstract Research conducted during the first 20 years of the AIDS epidemic provided a solid foundation of data supporting methadone
treatment as HIV prevention. Drug users in methadone treatment were consistently found to reduce the frequency of drug use,
risk behaviors, and infections. These data have been consistent over time and across cultural settings and have been used
to promote the expansion of drug treatment as a prevention intervention. More recently, data have emerged suggesting the prevention
potential of medication-assisted treatments other than methadone (buprenorphine/naloxone and naltrexone). Still, with a few
notable exceptions, global drug treatment coverage for opiate injectors remains remarkably low and only a few treatment interventions
for stimul…
Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects
Abstract: Previous reports have demonstrated greater antinociception following administration of a buprenorphine/naloxone combination compared to buprenorphine alone among healthy volunteers. The aim of the current investigation was to determine whether buprenorphine antinociception could be enhanced with the addition of ultra-low dose naltrexone, using a range of dose ratios. A repeated-measures, double-blind, cross-over trial was undertaken with 10 healthy participants. The effects of each buprenorphine:naltrexone ratio (100:1, 133:1, 166:1, and 200:1) on cold pressor tolerance time and respiration were compared to the effects of buprenorphine only. The 166:1 ratio was associated with significantly greater tolerance time to cold pressor pain than buprenorphine alone. Minimal respiratory …